Discover management strategies for alopecia areata, from anti-inflammatory diets to stress reduction techniques that can help ...

Medically reviewed by Susan Bard, MD Alopecia areata is a common hair loss condition. It affects people of all ages, races, ...

While similarities exist between types of alopecia, distinct clinical characteristics help patients & physicians ...

So fortunately, in the past year-plus, we have seen two oral [Janus kinase (JAK)] inhibitors be approved for alopecia areata, and these medicines are really pathogenesis-directed treatment ...

The Food and Drug Administration (FDA) has granted Fast Track designation to bempikibart for the treatment of alopecia areata (AA).

Significant unmet needs were found among high-quality validation studies on the internal structure of patient-reported ...

Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other autoimmune and inflammatory diseases, ...

When it comes to the world of hair loss, it’s no question that the amount of information out there can feel extremely overwhelming. Not only are there hundreds to thousands of products that swear they ...

has granted Fast Track designation to bempikibart for the treatment of Alopecia Areata (AA), an autoimmune disease that attacks hair follicles causing patchy hair loss. Fast Track is a process ...

April 30, 2025 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata (AA) and other ...